{ }
The Swiss stock market opened lower on Thursday, influenced by a slowdown in consumer price inflation, which rose by 0.8% year-on-year in September. The leading SMI index fell by 0.20%, with 25 of the 30 major stocks declining, while Sandoz, Novartis, and Givaudan were among the few gainers. Analysts anticipate a potential rate cut by the Swiss National Bank in December 2024 due to declining inflation forecasts.
US non-farm payrolls are expected to add 148,000 jobs in September, with the unemployment rate likely holding steady at 4.2%. Despite recent softer job data, a range of 120,000 to 180,000 job additions could indicate economic normalization rather than distress. The US dollar may stabilize, influenced by labor market resilience and geopolitical tensions, though caution remains due to high net-short positioning against G10 currencies.
IG
In Q3 2024, hospital merger and acquisition activity surged, with 27 transactions announced, the highest for that quarter since 2017, driven largely by the Steward Health Care bankruptcy. Total transacted revenue reached $13.3 billion, including four mega-mergers, as health systems adapt to community needs and financial challenges. Despite the high transaction volume, many struggling organizations face difficulties in finding partners, raising concerns about potential hospital closures.
As U.S. healthcare costs are projected to rise by 7.7% in 2025, employers are shifting strategies to enhance affordability without burdening employees. Over half plan to implement cost-reduction programs and explore alternative drug pricing, while 73% aim to carve out pharmacy benefits to manage expenses effectively. Key focus areas include obesity management, cancer care, and cardiovascular health, as companies seek innovative solutions to support workforce wellbeing.
The global telemedicine market is projected to exceed USD 14 billion by 2030, driven by the rising demand for regular health check-ups and the active participation of key industry players in innovation and partnerships. North America is expected to lead the market, with telemonitoring services showing significant revenue growth. Notable companies like Teladoc Health and Rudolf Riester GmbH are advancing the sector with new solutions, including AI-supported telemedicine tools and mobile clinics for remote areas.
The U.S. healthcare industry is experiencing a slowdown in hospital mergers and acquisitions following the acute phase of the COVID-19 pandemic. Health systems are prioritizing operational efficiency and exploring partnerships or sales agreements to better serve their communities. Thorough due diligence is crucial to mitigate financial and regulatory risks during this process.
The U.S. government is extending the negotiation process for drug price cuts under Medicare, allowing more opportunities for pharmaceutical companies to submit counter offers. The Centers for Medicare and Medicaid Services (CMS) will select the most expensive medications for negotiation by February 1, with new prices effective in 2027. Changes include earlier meetings with drugmakers and additional negotiation sessions to foster dialogue and potentially improve counteroffers.
Investing in healthcare ETFs offers Canadian investors a way to diversify their portfolios, which are often underweight in this sector. Despite its volatility, the healthcare sector is expected to see growth driven by an aging population, technological advancements, and increased healthcare spending. Funds like the Hamilton Healthcare Yield Maximizer ETF and Harvest Healthcare Leaders Income ETF utilize covered call strategies to enhance yields, appealing to those seeking defensive investments with growth potential.
Biocon Biologics has successfully priced its debut USD 800 million senior secured notes due 2029 at a 6.67% coupon, marking a significant milestone as the first USD bond issuance by a biopharmaceutical company in the Asia Pacific. The transaction, which is expected to settle on October 9, 2024, aims to refinance existing long-term debt of USD 1.1 billion, enhancing the company's financial flexibility and supporting its growth in the biosimilars market. The bond issuance received robust interest, with an oversubscription of over 3x, reflecting strong investor confidence in Biocon Biologics' credit profile and growth potential.
T-Mobile has reached a $31.5 million settlement with the FCC following multiple data breaches that compromised the personal information of millions of customers. The agreement includes a $15.75 million fine and an equal investment in cybersecurity improvements. The breaches affected approximately 37 million customers in January 2023, with previous incidents in 2022 and 2021 impacting 76 million accounts.
Trending
Subcategory:
Countries:
Companies:
Currencies:
People:

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Address

Waitlist

We’re granting exclusive early access to the first 500 users from december 20.

© 2024 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.